Navigation Links
Sangamo BioSciences Presents Clinical Data From SB-728-T HIV Study Demonstrating Long-Term Immune Reconstitution and Reduction in the HIV DNA Reservoir In Subjects with Long-Term Infection
Date:11/4/2013

RICHMOND, Calif., Nov. 4, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of clinical data from its program to develop a ZFP Therapeutic® for HIV/AIDS.  The data demonstrate a reduction in the HIV DNA reservoir since receiving SB-728-T in seven of nine HIV-infected subjects on long-term anti-retroviral therapy (ART), despite a median duration of HIV infection of 21 years and baseline CD4 T-cell counts prior to SB-728-T treatment of <500 cells/µl. The data were presented  at a translational medicine meeting organized by The Lancet and Cell publications and entitled, "What Will it Take to Achieve an AIDS-Free World?" which is being held in San Francisco, November 3-5, 2013.

(Logo:  http://photos.prnewswire.com/prnh/20130102/SF35903LOGO)

"These data are very promising and demonstrate the important link between SB-728-T treatment and immune reconstitution of central memory and total CD4 T cells and lower HIV DNA levels in subjects at 12 months," said Rafick-Pierre Sekaly, Ph.D., Co-Director & Chief Scientific Officer, The Vaccine & Gene Therapy Institute of Florida (VGTI Florida), who presented the data and whose laboratory carried out the immunologic analyses.

ART successfully suppresses viral load in most subjects, but a significant proportion, so called immunologic non-responders (INR), do not restore normal CD4 counts above 500 cells/µl.  HIV-infected subjects who were classified as INR, enrolled in Sangamo's ongoing SB-728-902 clinical trial (Cohorts 1-3), received a single infusion of SB-728-T which resulted in a durable increase in total CD4 T-cells associated wi
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sangamo BioSciences Presents Clinical Data From HIV Study Demonstrating Sustained Control Of Viremia
2. Sangamo BioSciences Announces Pricing Of Public Offering Of Common Stock
3. Sangamo BioSciences Announces Presentation of Clinical Data Demonstrating Functional Control of Viremia in HIV-Infected Subjects Treated with SB-728-T
4. Sangamo BioSciences to Acquire Ceregene
5. Sangamo BioSciences Announces Notice Of Allowance For New Patent Application Covering Genome Modification Technology
6. Sangamo BioSciences Reports Second Quarter 2013 Financial Results
7. Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
8. Sangamo BioSciences Announces Second Quarter 2013 Conference Call And Webcast
9. Sangamo BioSciences Reports First Quarter 2013 Financial Results
10. Sangamo BioSciences Announces First Quarter 2013 Conference Call and Webcast
11. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015 HeartWare International, ... of less invasive, miniaturized circulatory support technologies that are ... that its President and Chief Executive Officer, Doug ... Genuity 35th Annual Growth Conference at 8:30 a.m. EDT ... held August 12-13, 2015 at the InterContinental Boston. ...
(Date:8/4/2015)... LOS ANGELES , Aug. 4, 2015 ... the world,s leading provider of diagnostic information services, ... announced acquisition of MemorialCare Health System,s laboratory outreach ... of the transaction, patients and physicians now have ... and network of nearly 200 patient service centers ...
(Date:8/4/2015)... SAN FRANCISCO , Aug. 4, 2015 /PRNewswire/ ... Nicki Vasquez , Ph.D., as vice president ... have a leadership role in the management of ... cancer therapeutics pipeline, including antibody-drug conjugates, bispecific antibodies ... Dr. Vasquez brings more than 22 years of ...
Breaking Medicine Technology:HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2Quest Diagnostics Completes Acquisition of MemorialCare Health System's Laboratory Outreach Service Business in Southern California 2Sutro Biopharma Appoints Nicki Vasquez, Ph.D. as VP of Alliance and Project Management 2
... Mass., Jan. 17, 2012  CardioFocus, Inc., developer of ... treatment of atrial fibrillation (AF), announces that a ... Electrophysiology demonstrates the high acute and chronic ... procedure using HeartLight EAS. The study was conducted ...
... Inc. (NYSE Amex: PTN ) announced today ... of non-dilutive funding through the New Jersey Economic Development ... New Jersey net operating losses and research and development ... Palatin Technologies received approximately $637,000 under this program. ...
Cached Medicine Technology:Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation 2Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation 3Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation 4
(Date:8/4/2015)... ... August 04, 2015 , ... Worldwide Power Products acquires new ... its reach in Texas. Effective July 1st of this year, Worldwide Power Products ... With the North Texas acquisition, Worldwide Power Products (“WPP”) now services 1000 ...
(Date:8/4/2015)... ... 2015 , ... Recent studies in the United ... binge drinking among certain populations and specific locations. Researchers, who have ... trends and evidence to help facilitate health care treatment to meet current needs. ...
(Date:8/4/2015)... , ... August 04, 2015 , ... Members receiving care ... care metrics – at a cost that is nine percent lower -- than those ... Blue Shield of New Jersey’s patient-centered programs. , “The promise of patient-centered, or ...
(Date:8/4/2015)... ... August 04, 2015 , ... Buckeye Health ... kindergarten. All required immunizations are covered for members under the Healthchek program . ... aren’t caught up with their immunizations may not be allowed to attend when ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... manufacturing, label design, product packaging, and fulfillment services, joined over 200 other Long ... event was held on Tuesday, July 28th at Jones Beach State Park in ...
Breaking Medicine News(10 mins):Health News:North Texas Acquisition Press Release 2Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2
... available in Spanish . , The ... Clinical Research of European Legislation ) a project with ... the European Directive on Clinical Trials (2001/20/EC) in all ... also has the active participation of the different stakeholders: ...
... public policy effort to boost safety , , MONDAY, July 28 ... in your town or your route to work through an ... of the need to drive safely. , Researchers at ... (CERS) developed www.saferoadmaps.org, so you can simply enter your address ...
... launches new website offering convenient http://www.terrimilen.com [Online Counseling via ... comfort of their own home or office. , ... ... provide clients with an alternative to traditional therapy which requires clients ...
... sample traced back to Mexican farm, FDA announces ... a week after uncovering the first big clue in ... that tainted jalapeno peppers had been definitively traced to ... Drug Administration gave the all-clear to jalapeno and serrano ...
... to discuss second quarter financial results -, LAVAL, ... DDSS) today announced that it will host a conference ... discuss its second quarter 2008,financial results. Labopharm will report ... approximately 7:00 a.m. the same day., To access ...
... function, increases asthma risk, studies find, , , FRIDAY, July ... actually be bad for your health, depending on what ... , Recent research suggests that exposure to cleaning products ... compound (VOC) called 1,4 dicholorobenzene (1,4 DCB), can reduce ...
Cached Medicine News:Health News:Researchers Map America's Deadliest Roads 2Health News:Online Counseling and Life Coaching Practice Launches New Website 2Health News:Mexican Peppers ID'd as Salmonella Culprits 2Health News:Mexican Peppers ID'd as Salmonella Culprits 3Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3
... designed for the retraction of nerves, ... Reduced obstruction when working within a ... of blade sizes from 2 mm ... and release, malleable material allows preferred ...
Telescopic Diamond-Dissectors for delicate sharp tissue preparation. Total/working lengths 220/240 mm with protective sleeve....
Cobb Spinal Curettes, tip size 13.00 mm, length 11" (279 mm)....
Scoville Ruptured Disc Curettes, length 10" (254 mm), cup size 4 x 10 mm....
Medicine Products: